Physician profile
Faisal Jamal
NPI 1346207560
$855.47
in general payments reported to CMS, 2019-2025
6 companies · $43.51 in 2025
The $43.51 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.98 · 2023: $155 · 2024: $637 · 2025: $43.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $615 · Consulting Fee: $130 · Food and Beverage: $90.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $614.95 |
| Consulting Fee | $130.00 |
| Food and Beverage | $90.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $614.95 | 2024 | |
| Glaxosmithkline, LLC. | $130.00 | 2023 | Benlysta |
| Aurinia Pharma U.S., INC. | $43.84 | 2024-2025 | Lupkynis |
| Abbvie INC. | $24.95 | 2023 | |
| Travere Therapeutics, INC. | $21.75 | 2025 | Filspari |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $19.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Jamal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.